NU2RGH001917
Cooperative Agreement
Overview
Grant Description
Capacity Building for Global, Regional, and National Immunization Programs - Global Immunization Division, Centers for Disease Control and Prevention
This proposal aims to support the Centers for Disease Control and Prevention's (CDC) Global Immunization Division's (GID) goal of reducing the burden of vaccine-preventable diseases such as polio and increasing the capacity of global immunization programs.
Integral Global Health (IGH), with its registered office in Pakistan, will partner with the Public Health Institute (PHI), Chip Training and Consulting (CTC) with offices throughout Pakistan, and Riz Consulting (RIZ) with offices in the United Arab Emirates, Pakistan, and Afghanistan. Together, they will form the Integral Consortium to implement programs designed to assist GID in meeting its goals. The Integral Consortium has a strong foundation of previous experience working with GID in Pakistan. IGH's leadership includes a former staff member of the CDC who was assigned to the Global Polio Eradication Initiative (GPEI) in Pakistan. Additionally, the IGH Consortium brings a roster of partners currently working with GPEI partners in Afghanistan and Pakistan.
PHI brings a strong cadre of technical subject matter experts and former CDC staff with diverse experience in coalition building and a large global presence in several priority countries aligned with GID's routine immunization and vaccine-preventable disease (VPD) initiatives. This consortium has a strong on-the-ground infrastructure to rapidly engage partners such as the National Stop Transmission of Polio Program, provide program administration, and fiscal management at the national and provincial level in Afghanistan/Pakistan and globally. Additionally, the consortium brings the requisite past performance to serve as a strong technical backstop for GID's global needs. Globally, the IGH Consortium is prepared with a strong understanding of addressing the COVID-19 pandemic and the context of including the vaccine into routine immunization programs in the future as vaccine supplies become more available.
The Integral Consortium's proposal outlines projects in Pakistan, Afghanistan, and globally to address GID's short- and medium-term outcomes. The detailed activities outlined in the proposal will accomplish the following outcomes by the end of the five-year project period:
- Elimination of polio from Afghanistan and Pakistan
- Integration of the Polio Eradication Initiative with the country's Expanded Program on Immunization (EPI)
- Achievement of regional and national vaccine-preventable disease elimination goals
- Strong immunization systems in Afghanistan/Pakistan
- Strengthened COVID-19 and VPD data and surveillance systems
- Reduced COVID-19 and VPD-associated mortality and morbidity
- Increased government ownership of EPI programs
- Improved stakeholder consensus and coordination on immunization
This project will be supported by a strong monitoring and evaluation plan that will collect performance and evaluation data influencing management decision-making and resource allocation. It will track program implementation against targets using annual benchmarks, develop implementation tactics and strategies, communicate and report on program results, and contribute to CDC's strategic objectives.
This proposal aims to support the Centers for Disease Control and Prevention's (CDC) Global Immunization Division's (GID) goal of reducing the burden of vaccine-preventable diseases such as polio and increasing the capacity of global immunization programs.
Integral Global Health (IGH), with its registered office in Pakistan, will partner with the Public Health Institute (PHI), Chip Training and Consulting (CTC) with offices throughout Pakistan, and Riz Consulting (RIZ) with offices in the United Arab Emirates, Pakistan, and Afghanistan. Together, they will form the Integral Consortium to implement programs designed to assist GID in meeting its goals. The Integral Consortium has a strong foundation of previous experience working with GID in Pakistan. IGH's leadership includes a former staff member of the CDC who was assigned to the Global Polio Eradication Initiative (GPEI) in Pakistan. Additionally, the IGH Consortium brings a roster of partners currently working with GPEI partners in Afghanistan and Pakistan.
PHI brings a strong cadre of technical subject matter experts and former CDC staff with diverse experience in coalition building and a large global presence in several priority countries aligned with GID's routine immunization and vaccine-preventable disease (VPD) initiatives. This consortium has a strong on-the-ground infrastructure to rapidly engage partners such as the National Stop Transmission of Polio Program, provide program administration, and fiscal management at the national and provincial level in Afghanistan/Pakistan and globally. Additionally, the consortium brings the requisite past performance to serve as a strong technical backstop for GID's global needs. Globally, the IGH Consortium is prepared with a strong understanding of addressing the COVID-19 pandemic and the context of including the vaccine into routine immunization programs in the future as vaccine supplies become more available.
The Integral Consortium's proposal outlines projects in Pakistan, Afghanistan, and globally to address GID's short- and medium-term outcomes. The detailed activities outlined in the proposal will accomplish the following outcomes by the end of the five-year project period:
- Elimination of polio from Afghanistan and Pakistan
- Integration of the Polio Eradication Initiative with the country's Expanded Program on Immunization (EPI)
- Achievement of regional and national vaccine-preventable disease elimination goals
- Strong immunization systems in Afghanistan/Pakistan
- Strengthened COVID-19 and VPD data and surveillance systems
- Reduced COVID-19 and VPD-associated mortality and morbidity
- Increased government ownership of EPI programs
- Improved stakeholder consensus and coordination on immunization
This project will be supported by a strong monitoring and evaluation plan that will collect performance and evaluation data influencing management decision-making and resource allocation. It will track program implementation against targets using annual benchmarks, develop implementation tactics and strategies, communicate and report on program results, and contribute to CDC's strategic objectives.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Atlanta,
Georgia
United States
Geographic Scope
City-Wide
Related Opportunity
Analysis Notes
COVID-19 $2,434,794 (9%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Amendment Since initial award the total obligations have increased 427% from $5,000,000 to $26,341,453.
Amendment Since initial award the total obligations have increased 427% from $5,000,000 to $26,341,453.
Integral Global Health was awarded
Capacity Building for Global Immunization Programs - CDC
Cooperative Agreement NU2RGH001917
worth $26,341,453
from Center for Global Health in August 2021 with work to be completed primarily in Atlanta Georgia United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security.
The Cooperative Agreement was awarded through grant opportunity Capacity Building for Global, Regional, and National Immunization Programs.
Status
(Ongoing)
Last Modified 5/5/25
Period of Performance
8/1/21
Start Date
7/31/26
End Date
Funding Split
$26.3M
Federal Obligation
$0.0
Non-Federal Obligation
$26.3M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU2RGH001917
Additional Detail
Award ID FAIN
NU2RGH001917
SAI Number
NU2RGH001917-4184457615
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CW00 CDC CENTER FOR GLOBAL HEALTH
Awardee UEI
Y2KNANNC9FK5
Awardee CAGE
87P38
Performance District
GA-90
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Global Health, Centers for Disease Control and Prevention, Health and Human Services (075-0955) | Health care services | Grants, subsidies, and contributions (41.0) | $11,470,659 | 79% |
CDC-Wide Activities and Program Support, Centers for Disease Control and Prevention, Health and Human Services (075-0943) | Health care services | Grants, subsidies, and contributions (41.0) | $2,434,794 | 17% |
HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Health and Human Services (075-0950) | Health care services | Grants, subsidies, and contributions (41.0) | $628,000 | 4% |
Modified: 5/5/25